Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Volume 31, Number 10—October 2025

Dispatch

Emergence of Bordetella holmesii–Associated Pertussis-Like Illness, Northern India, 2019–2023

Nishant Shekhar, Deepa Sharma, Surajit Chakraborty, Rajesh Kumar, Rajneesh Singh Rawat, Nirmal Kaundal, Pawan Kumar, Tigran Avagyan, Deeksha Chauhan, Neha Jain, Megha Sharma, Arun Kumar, and Vikas GautamComments to Author 
Author affiliation: Post Graduate Institute of Medical Education and Research, Chandigarh, India (N. Shekhar, R. Kumar, R.S. Rawat, D. Chauhan, V. Gautam); World Health Organization Country Office India, New Delhi, India (D. Sharma, N. Kaundal, T. Avagyan); University of Miami Miller School of Medicine, Miami, Florida, USA (S. Chakraborty); India Ministry of Health and Family Welfare, New Delhi (P. Kumar); Yatharth Hospital, Noida, India (N. Jain); All India Institute of Medical Science−Bilaspur, Bilaspur, India (M. Sharma)

Main Article

Table 2

Pertussis toxin IgG seroprevalence of real-time quantitative PCR–confirmed Bordetella pertussis and B. holmesii cases in study of emergence of B. holmesii–associated pertussis-like illness, northern India, 2019–2023

Serology B. pertussis B. holmesii Co-infection with B. pertussis and B. holmesii
Positive 9 43 5
Negative
 32
 78
 7
Total 41 121 12

Main Article

Page created: September 02, 2025
Page updated: September 25, 2025
Page reviewed: September 25, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external